It’s been almost two full weeks since the ADA conference ended and we’re still trying to make sense of it all. What’s pretty obvious is that Dexcom up 10.6% and Insulet up 5.3% were the big winners in terms of stock price appreciation. Everyone else has basically tread water.
Everyone seems to think its big news that Dexcom intimated but did not come right out and state that their sensor will send readings directly to the Apple Watch. Everyone but us that is for what have we been saying consistently Apple and Dexcom are . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.